L. was later on terminated due to elevated liver function checks. Next, the patient was treated with cyclosporine, which was terminated because of high blood pressure and followed by methotrexate. Because of nausea, methotrexate dose was never improved beyond 12.5 mg/week. The patient then elected to participate in an interleukin-10 study protocol, which was halted after 6 months because of insufficient improvement. In February 2001, she began receiving 25 mg of etanercept (Enbrel), a tumor necrosis element alpha (TNF-) blocker, subcutaneously twice weekly, which was well tolerated and offered adequate control of disease activity. Five months later on, however, acute swelling of the right shoulder joint started. Because septic arthritis was suspected, etanercept was replaced by oral prednisolone, and the joint was tapped several times. Cultures, however, remained sterile. Because of chronic swelling of the right shoulder joint, the patient was referred to our division 5 months later on. At presentation, the right shoulder joint was inflamed and tender, with decreased range of motion. No redness or local elevation of the skin heat was found. No fever was detectable and no night time sweats were reported. The heart rate was 88/min, and blood pressure was 160/70 mm Hg. Laboratory evaluation found elevated acute-phase reactants (erythrocyte sedimentation rate, 83 mm/h; C-reactive protein, 3.56 mg/dl). Simple X-ray films of both shoulder joints were unremarkable (Fig. ?(Fig.1A).1A). Sonography of the right shoulder exposed synovitis and chronic bursitis. Magnetic resonance imaging showed massive joint effusions in the subacromial and subdeltoid bursa (Fig. 1B and C). Because septic arthritis was suspected, arthrocentesis of the inflamed right shoulder was performed and 70 ml of moderately cloudy inflammatory synovial fluid was aspirated and positively cultured for sensitive to aminopenicillins. Tradition was performed on Columbia CNA agar with 5% sheep blood (Becton Dickinson Microbiology Systems, Cockeysville, MD), and recognition of was carried out by API-Listeria kit (Biomerieux, Marcy l’Etoile, France). As a result, antibiotic therapy with intravenous ampicillin (2 g three times Zalcitabine daily) was started. Four additional arthrocenteses were performed, the first of which was again positive for in a patient treated with the TNF- blocker etanercept, which is a fusion protein of the human being TNF- receptor 2 and the Fc portion of human being immunoglobulin G. is definitely a gram-positive, Zalcitabine facultatively intracellular bacillus that can be isolated from a large number of Capn2 environmental sources. infection is relatively rare, with an estimated 2,500 instances per year Zalcitabine in the United States. It mostly affects debilitated individuals, such as those with malignancy, the immunosuppressed, such as transplant recipients, and the elderly. Whereas immunocompetent individuals usually present with nonspecific flu-like symptoms, lymphadenopathy, and gastrointestinal symptoms, immunocompromised individuals can develop meningoencephalitis and sepsis, with an overall mortality as high as 15 to 30% (39). Furthermore, in pregnant women, infection with can be transmitted to the fetus, leading to septicemia and fetal loss. The majority of sporadic instances are associated with contamination of unpasteurized dairy products, although additional modes of transmission may also be involved. Rare epidemic instances of listeriosis have also been traced to exposure to contaminated food (12). Infectious arthritis caused by is usually a rare event. A review of the literature revealed 29 reported cases (1, 2, 4, 5, 7-9, 11, 13, 14, 19, 25-27, 30-33, 35, 36, 40, 41, 43, 45, 47) (Table ?(Table1).1). The median age was 55 years (range, 22 to 80 years). Typically, disease emerged as monoarthritis of a large joint, such as the hip or knee, whereas only 9 cases involved more than one joint. The majority.